drugset / Trial / NCT05745987
Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT
RandomizedParallel-groupTriple-blindPrevention
Summary
A cluster randomized controlled trial to determine if smallpox vaccine reduces secondary cases and symptom severity in persons exposed to mpox.
Timeline
- Start
- 2024-09-17
- Primary completion
- 2026-06-01
- Completion
- 2026-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IMVAMUNE | Vaccine | 0.5 ml | — |
| Comparator | Typhim Vi | Vaccine | 0.5 ml | — |